These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 28423513

  • 1. miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.
    Xu K, Chen G, Qiu Y, Yuan Z, Li H, Yuan X, Sun J, Xu J, Liang X, Yin P.
    Oncotarget; 2017 Mar 28; 8(13):21719-21732. PubMed ID: 28423513
    [Abstract] [Full Text] [Related]

  • 2. MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17.
    Xu K, Liang X, Shen K, Sun L, Cui D, Zhao Y, Tian J, Ni L, Liu J.
    Exp Cell Res; 2012 Oct 15; 318(17):2168-77. PubMed ID: 22677042
    [Abstract] [Full Text] [Related]

  • 3. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H, Yin Y, Hu Y, Feng Y, Bian Z, Yao S, Li M, You Q, Huang Z.
    Pathol Res Pract; 2016 Jul 15; 212(7):643-9. PubMed ID: 27173050
    [Abstract] [Full Text] [Related]

  • 4. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J, Cai G, Xu Y, Cai S.
    Curr Mol Med; 2016 Jul 15; 16(1):70-82. PubMed ID: 26695693
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10.
    Zhang Y, Hu X, Miao X, Zhu K, Cui S, Meng Q, Sun J, Wang T.
    J Cell Mol Med; 2016 Feb 15; 20(2):360-9. PubMed ID: 26647742
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.
    Xu K, Zhan Y, Yuan Z, Qiu Y, Wang H, Fan G, Wang J, Li W, Cao Y, Shen X, Zhang J, Liang X, Yin P.
    Mol Ther; 2019 Oct 02; 27(10):1810-1824. PubMed ID: 31208913
    [Abstract] [Full Text] [Related]

  • 7. MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
    Ma F, Song H, Guo B, Zhang Y, Zheng Y, Lin C, Wu Y, Guan G, Sha R, Zhou Q, Wang D, Zhou X, Li J, Qiu X.
    Oncotarget; 2015 Jul 10; 6(19):17404-16. PubMed ID: 25965817
    [Abstract] [Full Text] [Related]

  • 8. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
    Li Q, Liang X, Wang Y, Meng X, Xu Y, Cai S, Wang Z, Liu J, Cai G.
    Sci Rep; 2016 May 31; 6():27157. PubMed ID: 27244080
    [Abstract] [Full Text] [Related]

  • 9. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T, Hou J, Liu C, Shan F, Xiong X, Qin A, Chen J, Ren W.
    Biomed Pharmacother; 2019 Sep 31; 117():109171. PubMed ID: 31261026
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
    Wang H, Li H, Zhang L, Yang D.
    Biomed Pharmacother; 2018 Oct 31; 106():1607-1615. PubMed ID: 30119236
    [Abstract] [Full Text] [Related]

  • 11. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li Y, Li Z, Ng SS, Sung JJ, Shen L, Yu J.
    Oncogene; 2015 Jul 30; 34(31):4142-52. PubMed ID: 25362853
    [Abstract] [Full Text] [Related]

  • 12. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A.
    Eur J Cancer; 2014 Apr 30; 50(6):1207-21. PubMed ID: 24412052
    [Abstract] [Full Text] [Related]

  • 13. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.
    Shang Y, Feng B, Zhou L, Ren G, Zhang Z, Fan X, Sun Y, Luo G, Liang J, Wu K, Nie Y, Fan D.
    Oncotarget; 2016 Jan 05; 7(1):538-49. PubMed ID: 26623719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.